BLU2864

DESCRIPTION

BLU2864 is an orally active, highly selective, ATP-competitive PRKACA inhibitor (IC50=0.3 nM). BLU2864 shows anti-tumor activity. BLU2864 can be used in cancer and polycystic kidney disease research[1][2].

DETAILS

Purity: >98%
Smiles: FC1=CC(C(F)F)=CC2=C1[C@H]([C@@H](O)C2)NC(C(C=C3)=CN=C3C4=C(C(C)=CN5)C5=NC=C4)=O
Category: Reference compound
Lead Time: 1-2 days
Cas Number: 2810747-89-6
Molecular Weight: 452.43
Molecular Formula: C24H19F3N4O2

Lead Time: 1 - 2 weeks